Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 7022-7035
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7022
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.7022
Table 1 Predictive factor for response of preoperative chemoradiation therapy for rectal cancer in the literature
Ref. | Study design | pCR (%) | Related factor with response of preoperative CRT | Independent factor for pCR |
Restivo et al[7], 2013 | Prospective (n = 260) | 16.5% | CEA < 5 ng/mL and distance from anal verge > 5 cm | |
Huh et al[8], 2013 | Retrospective (n = 391) | 14.6% | Noncircumferential tumors, nonmacroscopic ulceration, WELL differentiation, Early T, N stage, low level of pretreatment CEA | Tumor circumferentiality, macroscopic ulceration, pretreatment CEA < 5 ng/mL |
Wallin et al[9], 2013 | Retrospective (n = 469) | 20.0% | Pretreatment CEA ≤ 5 ng/mL | |
Kleiman et al[10], 2015 | Prospective (n = 141) | 13.5% | Low post CRT CEA level, normalization of CEA from initial elevated; CEA level | |
Hu et al[11], 2018 | Prospective (n = 146) | 15.0% | CEA exponential decrease group between pretreatment and during-CRT: Higher rates of downstaging and pCR | CEA clearance pattern |
Yamamoto et al[12], 2019 | Prospective (n = 111) | Combination of lymphocyte to monocyte ratio (LMR) and ypN; status: poor prognosis | Low pretreatment LMR ypN(+) |
- Citation: Cheong C, Shin JS, Suh KW. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer. World J Gastroenterol 2020; 26(44): 7022-7035
- URL: https://www.wjgnet.com/1007-9327/full/v26/i44/7022.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i44.7022